Roni Haklai

2.3k total citations
37 papers, 1.9k citations indexed

About

Roni Haklai is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Roni Haklai has authored 37 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 9 papers in Oncology and 8 papers in Cell Biology. Recurrent topics in Roni Haklai's work include Protein Kinase Regulation and GTPase Signaling (12 papers), Protein Tyrosine Phosphatases (6 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Roni Haklai is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (12 papers), Protein Tyrosine Phosphatases (6 papers) and Cytokine Signaling Pathways and Interactions (6 papers). Roni Haklai collaborates with scholars based in Israel, United States and Germany. Roni Haklai's co-authors include Yoel Kloog, Galit Elad‐Sfadia, Ariella Paz, Yoel Kloog, Yaakov Egozi, Daniele Marciano, Gilad Ben‐Baruch, Barak Rotblat, Hans‐Joachim Gabius and Marcelo Ehrlich and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and PLoS ONE.

In The Last Decade

Roni Haklai

37 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roni Haklai Israel 21 1.4k 605 472 247 162 37 1.9k
Carina Hellberg Sweden 24 1.4k 1.0× 557 0.9× 346 0.7× 303 1.2× 235 1.5× 35 2.0k
Mikiro Takaishi Japan 23 701 0.5× 701 1.2× 296 0.6× 176 0.7× 114 0.7× 45 1.7k
Elisabetta Rovida Italy 28 1.1k 0.7× 419 0.7× 395 0.8× 164 0.7× 365 2.3× 78 2.0k
James L. Clements United States 20 1.0k 0.7× 1.2k 2.0× 429 0.9× 146 0.6× 166 1.0× 41 2.3k
Alison M. Michie United Kingdom 27 1.2k 0.9× 1.0k 1.7× 486 1.0× 137 0.6× 304 1.9× 67 2.5k
Ksenya Shchors United States 17 1.3k 0.9× 475 0.8× 593 1.3× 121 0.5× 393 2.4× 18 2.0k
Galit Elad‐Sfadia Israel 15 899 0.6× 589 1.0× 271 0.6× 134 0.5× 102 0.6× 23 1.3k
Christine Tan United States 10 1.2k 0.8× 318 0.5× 487 1.0× 187 0.8× 243 1.5× 17 1.9k
Karen Keeshan United Kingdom 26 1.4k 1.0× 406 0.7× 302 0.6× 557 2.3× 195 1.2× 55 2.2k
Xiaochun Xu United States 19 1.3k 0.9× 366 0.6× 505 1.1× 240 1.0× 507 3.1× 36 2.0k

Countries citing papers authored by Roni Haklai

Since Specialization
Citations

This map shows the geographic impact of Roni Haklai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roni Haklai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roni Haklai more than expected).

Fields of papers citing papers by Roni Haklai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roni Haklai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roni Haklai. The network helps show where Roni Haklai may publish in the future.

Co-authorship network of co-authors of Roni Haklai

This figure shows the co-authorship network connecting the top 25 collaborators of Roni Haklai. A scholar is included among the top collaborators of Roni Haklai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roni Haklai. Roni Haklai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Altshuler, Anna, Ifat Abramovich, Roni Haklai, et al.. (2018). RAS Regulates the Transition from Naive to Primed Pluripotent Stem Cells. Stem Cell Reports. 10(3). 1088–1101. 20 indexed citations
2.
Abramovitch, Shirley, et al.. (2014). Vitamin D and S-Farnesylthiosalicylic Acid Have a Synergistic Effect on Hepatic Stellate Cells Proliferation. Digestive Diseases and Sciences. 59(10). 2462–2469. 15 indexed citations
3.
Kloog, Yoel, Galit Elad‐Sfadia, Roni Haklai, & Adam Mor. (2013). Ras Chaperones. ˜The œEnzymes. 33 Pt A. 267–289. 8 indexed citations
4.
Oron, Tal, Galit Elad‐Sfadia, Roni Haklai, et al.. (2011). Prevention of Induced Colitis in Mice by the Ras Antagonist Farnesylthiosalicylic Acid. Digestive Diseases and Sciences. 57(2). 320–326. 10 indexed citations
5.
Haklai, Roni, et al.. (2011). Farnesylthiosalicylic acid (salirasib) inhibits Rheb in TSC2‐null ELT3 cells: A potential treatment for lymphangioleiomyomatosis. International Journal of Cancer. 130(6). 1420–1429. 14 indexed citations
6.
Nevo, Yoram, Shlomit Aga‐Mizrachi, Galit Elad‐Sfadia, et al.. (2011). The Ras Antagonist, Farnesylthiosalicylic Acid (FTS), Decreases Fibrosis and Improves Muscle Strength in dy2J/dy2J Mouse Model of Muscular Dystrophy. PLoS ONE. 6(3). e18049–e18049. 20 indexed citations
7.
Rotblat, Barak, Liang Hong, Roni Haklai, et al.. (2010). H-Ras Nanocluster Stability Regulates the Magnitude of MAPK Signal Output. PLoS ONE. 5(8). e11991–e11991. 33 indexed citations
8.
Gottfried, Irit, et al.. (2009). Rasosomes spread Ras signals from plasma membrane ‘hotspots’. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1793(11). 1691–1702. 8 indexed citations
9.
Haklai, Roni, Galit Elad‐Sfadia, Yaakov Egozi, & Yoel Kloog. (2007). Orally administered FTS (salirasib) inhibits human pancreatic tumor growth in nude mice. Cancer Chemotherapy and Pharmacology. 61(1). 89–96. 62 indexed citations
10.
Rotblat, Barak, Ofer Yizhar, Roni Haklai, Uri Ashery, & Yoel Kloog. (2006). Ras and Its Signals Diffuse through the Cell on Randomly Moving Nanoparticles. Cancer Research. 66(4). 1974–1981. 32 indexed citations
11.
Elad, David, et al.. (2006). Custom-Designed Wells and Flow Chamber for Exposing Air–Liquid Interface Cultures to Wall Shear Stress. Annals of Biomedical Engineering. 34(12). 1890–1895. 14 indexed citations
12.
Elad‐Sfadia, Galit, et al.. (2004). Galectin-3 Augments K-Ras Activation and Triggers a Ras Signal That Attenuates ERK but Not Phosphoinositide 3-Kinase Activity. Journal of Biological Chemistry. 279(33). 34922–34930. 242 indexed citations
13.
Elad‐Sfadia, Galit, et al.. (2002). Galectin-1 Augments Ras Activation and Diverts Ras Signals to Raf-1 at the Expense of Phosphoinositide 3-Kinase. Journal of Biological Chemistry. 277(40). 37169–37175. 184 indexed citations
14.
Paz, Ariella, et al.. (2001). Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation. Oncogene. 20(51). 7486–7493. 327 indexed citations
15.
Paz, Ariella, et al.. (1999). Targeting of K-Ras 4B by S-trans,trans-farnesyl thiosalicylic acid. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1452(3). 228–242. 66 indexed citations
16.
Haklai, Roni, Mali Gana Weisz, Ariella Paz, et al.. (1998). Dislodgment and Accelerated Degradation of Ras. Biochemistry. 37(5). 1306–1314. 179 indexed citations
17.
Gana‐Weisz, Mali, et al.. (1998). Stringent structural requirements for anti-Ras activity of S-prenyl analogues. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1406(1). 40–50. 51 indexed citations
18.
Ben‐Baruch, Gilad, et al.. (1995). Farnesyl Derivatives of Rigid Carboxylic Acids - Inhibitors of ras-Dependent Cell Growth. Journal of Medicinal Chemistry. 38(8). 1267–1272. 105 indexed citations
19.
Haklai, Roni & Yoel Kloog. (1991). Relationship among methylation, isoprenylation, and GTP binding in 21-to 23-kDa proteins of neuroblastoma. Cellular and Molecular Neurobiology. 11(4). 415–433. 10 indexed citations
20.
Haklai, Roni & Yoel Kloog. (1990). Methylation of 21–23 kD membrane proteins by a membrane-associated protein carboxyl methyltransferase in neuroblastoma cells. Biochemical Pharmacology. 40(6). 1365–1372. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carina Hellberg Breakdown of academic impact, for papers by Mikiro Takaishi Breakdown of academic impact, for papers by Elisabetta Rovida Breakdown of academic impact, for papers by James L. Clements Breakdown of academic impact, for papers by Alison M. Michie Breakdown of academic impact, for papers by Ksenya Shchors Breakdown of academic impact, for papers by Galit Elad‐Sfadia Breakdown of academic impact, for papers by Christine Tan Breakdown of academic impact, for papers by Karen Keeshan Breakdown of academic impact, for papers by Xiaochun Xu
Rankless by CCL
2026